Clinical Trial Update: Alignment of PrEP Use With HIV Risk in Young Women and Men [Phase 4]

View source ↗

Summary

Phase 4 study examining alignment of pre-exposure prophylaxis (PrEP) use with HIV risk among young women and men; the trial is completed and results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: University of Washington | Conditions: Pre-Exposure Prophylaxis, Sexually Transmitted Diseases, Bacterial | Phase 4 | Status: COMPLETED | Results posted: 2025-06-17